Refine by
Neurodegeneration Suppliers & Manufacturers
59 companies found
based inYokohama, JAPAN
We provide a unique combination of services and products to power your translational research. With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into ...
based inDoylestown, PENNSYLVANIA (USA)
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...
Neuropathix has focused its science on the research and development of a pipeline of next generation socially responsible pain management ...
based inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
Clinical grade human astrocytes (the nervous system supporting cells) for the treatment of ALS and other neurodegenerative diseases. Received approval by the Israeli Ministry of Health to commence our phase I/IIa clinical trial in ALS patients. 6 ...
based inMarseille, FRANCE
Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases and neuronal impairment-induced ...
To keep up its high level of Competitiveness, Neuron Experts constantly develops new cellular models to provide the most accurate answers to customers’ needs: Development of new neurodegenerative disease models following current discoveries of ...
based inWoburn, MASSACHUSETTS (USA)
As the scientific leader in the biological role of the microbiome gut-brain axis and its impact on neurological conditions, Axial Therapeutics is uniquely positioned to advance a fundamentally different therapeutic approach for the treatment of ...
based inBoston, MASSACHUSETTS (USA)
Founded by Flagship Pioneering, Valo is a mission-driven technology company that was created with the belief that the drug discovery and development process can and should be better—faster, less expensive, and with a higher probability of success. ...
based inEncinitas, CALIFORNIA (USA)
Neurodigitech (NDT) is dedicated to 1) Neurohistological and neuropathological services of the central nervous system (CNS), 2) Neural staining kits, 3) High-throughput digital microscopic imaging and stereology-based quantitative morphology, and 4) ...
The NDT teams in specialized in both non-GLP and GLP compliant pre-clinical assessments of CNS disease therapeutics using a variety of biomarkers, including histology, immunohistochemical and histochemical methods. In particular, NDT is dedicated to ...
based inNY, NEW YORK (USA)
We are committed to developing new areas such as mitochondrial genome sequencing, gene mutation, comparative genomics and epigenetics, and provide highly customized services. Creative Biogene provides a comprehensive range of Separation & Extraction ...
Creative Biogene provides the fractionated mitochondrial magnetic separation (FMMS) method to increase the production of brain-derived mitochondria compared with the UC method and can better detect mitochondrial damage in the central nervous system ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
During ReGen’s discussions with potential licensing partners in 2004, it became apparent that a product based on the Colostrinin™ complex, as a whole, was more commercially attractive as a nutraceutical, rather than as a pharmaceutical. ...
based inToronto, ONTARIO (CANADA)
Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI. Programming RNA Therapies Any Gene, Any Genetic Condition. Revolutions in AI, RNA biology and automation ...
based inMonterey, CALIFORNIA (USA)
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug Designation from the FDA for INT41 to treat Huntington’s disease a ...
INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease. IND enabling studies for INT41 Gene Therapy for Huntington’s disease are in place following a preIND meeting with the FDA in in February 2022 in response ...
based inSan Diego, CALIFORNIA (USA)
Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...
For the assessment of multiple sclerosis and other neurodegenerative conditions. Automatically label, visualize and obtain the volumetric quantification of segmentable brain structures and lesions from MRI brain studies—within minutes. ...
based inMadison, WISCONSIN (USA)
Stem Pharm offers unique biomaterials for cell and tissue manufacturing. Applications include stem cell derived in vitro models for drug discovery and matrices for cell therapy and regenerative medicine. Stem Pharm was founded in 2015 with the ...
Stem Pharm’s advanced neural organoid models uniquely contain microglia and provide new opportunities to investigate CNS disease modeling, drug discovery, and toxicology applications. ...
based inMagdeburg, GERMANY
HASOMED GmbH is an owner-managed family business. We grow from our own resources, independent of outside capital, 'with our feet on the ground'. The management acts in Christian responsibility. Committed employees are the most important capital of ...
based inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Krabbe disease is a severe neurodegenerative disorder caused by mutations in GALC, the gene that encodes the galactosylceramidase (GALC) enzyme. These mutations cause GALC misfolding and dysfunction, which leads to the toxic buildup up fats in the ...
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier ...
based inBingham, MICHIGAN (USA)
In 2017, a group of internationally-recognized MRI industry professionals and entrepreneurs founded SpinTech, Inc. with the goal of transforming advanced MRI techniques, previously reserved only for the research realm, into practical applications to ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening ...
based inParis, FRANCE
Iconeus, based in Paris, is renowned for pioneering the functional ultrasound technology specifically designed for imaging cerebrovascular activity. Their flagship product, the Iconeus One, integrates high-sensitivity, high-speed, and ...
based inWhite Plains, NEW YORK (USA)
Oligomerix is a biotechnology company focused on developing disease-modifying and treatment therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy ...
There exist numerous rare diseases that tau dysfunction is associated with known as tauopathies. While Alzheimer’s is the largest tauopathy, other tauopathies are rare diseases that present accelerated regulatory pathways and significant ...